All NIH Funding Opportunities and Notices

• Notice of NIA Participation in PAR-07-018, “Understanding and Promoting Health Literacy (R21)”
  (NOT-AG-09-001)
  National Institute on Aging
  

• Change of Application Due Date for RFA-AI-08-055, Innovative Approaches to Target Identification and Assay Development for Fungal Diagnosis (R21/R33)
  (NOT-AI-09-006)
  National Institute of Allergy and Infectious Diseases
  

• Change of Submission Due Dates for RFA-AI-08-053, Basic HIV Vaccine Discovery Research (R01)
  (NOT-AI-09-007)
  National Institute of Allergy and Infectious Diseases
  

• Announcement of Participation of NCI on RFA-NR-09-002, Centers of Excellence in Symptom Management or Centers of Excellence in Health Promotion/Disease Prevention (P30)
  (NOT-CA-09-002)
  National Cancer Institute
  

• Discontinued Availability of Custom Case Sets of Full Tissue Sections from the NCI Cooperative Breast Cancer Tissue Resource (CBCTR)
  (NOT-CA-09-003)
  National Cancer Institute
  

• Tissue Microarrays Available for Investigations of Prognostic Breast Cancer Biomarkers
  (NOT-CA-09-004)
  National Cancer Institute
  

• Request for Information (RFI): Ongoing Research and Research Needs for Biological Effects of Exposure to Bisphenol A (BPA)
  (NOT-ES-09-001)
  National Institute of Environmental Health Sciences
  

• FAQs Related to RFA-HL-09-002: Cardiac Development Consortium, RFA-HL-09-003: Pediatric Cardiac Genomics Consortium, and RFA-HL-09-011: Pediatric Translational Consortium Administrative Coordinating Center
  (NOT-HL-09-108)
  National Heart, Lung, and Blood Institute
  

• Request for Information: Nomination of Monoclonal Antibody Targets for Epigenetic Research
  (NOT-RM-09-003)
  NIH Roadmap Initiatives
  

• Notice of Correction to PAR-08-262 Limited Competition for Research Centers in Minority Institutions Infrastructure for Clinical and Translational Research (RCTR)
  (NOT-RR-09-001)
  

• Cancer Disparities Research Partnership (CDRP) Program: Limited Competition (U54)
  (RFA-CA-09-502)
  National Cancer Institute
  Application Receipt Date(s): December 22, 2008
  

• The Mouse Gene Development Initiative (R01)
  (RFA-DA-09-015)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): January 27, 2009
  

• Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R01)
  (RFA-DA-09-017)
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): January 28, 2009
  

• Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R21)
  (RFA-DA-09-018)
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): January 28, 2009
  

• Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R03)
  (RFA-DA-09-019)
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): January 28, 2009
  

• Pediatric Pharmacology and Therapeutics Research Consortium (PPTRC) (U54)
  (RFA-HD-08-021)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 05, 2008
  

• Clinical Pharmacotherapy for PTSD: Single and Collaborative Studies (R34)
  (RFA-MH-09-090)
  National Institute of Mental Health
  Center for Scientific Review
  Application Receipt Date(s): January 14, 2009
  

• Basic and Preclinical Research on Complementary and Alternative Medicine (CAM) (R01)
  (PA-09-010)
  National Center for Complementary and Integrative Health
  National Cancer Institute
  Office of Dietary Supplements
  Application Receipt Date(s): Mutliple dates, see announcement.
  
  

• Contextual Approaches to Prevention ofUnintended Pregnancy (R01)
  (PA-09-014)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Contextual Approaches to Prevention ofUnintended Pregnancy (R21)
  (PA-09-015)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)
  (PAR-09-011)
  National Institute on Drug Abuse
  Application Receipt Date(s): December 15, 2008, July 15, 2009, December 15, 2009, July 15, 2010, December 15, 2010, July 15, 2011
  
  

• Pre-Application for the 2009 NIH Directors Pioneer Award Program (X02)
  (PAR-09-012)
  NIH Roadmap Initiatives
  Application Receipt Date(s): December 17, 2008
  
  

• Pre-Application for the 2009 NIH Directors New Innovator Award Program (X02)
  (PAR-09-013)
  NIH Roadmap Initiatives
  Application Receipt Date(s): January 15, 2009
  
  

  Past Tables of Contents

Department of Health and Human Services

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892